参考文献/References:
[1] Young WF Jr. Diagnosis and treatment of primary aldosteronism:practical clinical perspectives[J]. J Intern Med,2019,285(2):126-148.DOI:10.1111/joim.12831.
[2] Funder JW,Carey RM,Mantero F,et al. The management of primary aldosteronism:case detection,diagnosis,and treatment:an endocrine society clinical practice guideline[J]. J Clin Endocrinol Metab,2016,101(5):1889-1916.DOI:10.1210/jc.2015-4061.
[3] Young WF. Primary aldosteronism:renaissance of a syndrome[J]. Clin Endocrinol(Oxf),2007,66(5):607-618.DOI:10.1111/j.1365-2265.2007.02775.x.
[4] Funder JW. Primary aldosteronism:the next five years[J]. Horm Metab Res,2017,49(12):977-983.DOI:10.1055/s-0043-119802.
[5] Mulatero P,Monticone S,Burrello J,et al. Guidelines for primary aldosteronism:uptake by primary care physicians in Europe[J]. J Hypertens,2016,34(11):2253-2257.DOI:10.1097/HJH.0000000000001088.
[6] Xu Z,Yang J,Hu J,et al. Primary aldosteronism in patients in China with recently detected hypertension[J]. J Am Coll Cardiol,2020,75(16):1913-1922.DOI:10.1016/j.jacc.2020.02.052.
[7] Mulatero P,Monticone S,Deinum J,et al. Genetics,prevalence,screening and confirmation of primary aldosteronism:a position statement and consensus of the Working Group on Endocrine Hypertension of The European Society of Hypertension[J]. J Hypertens,2020,38(10):1919-1928.DOI:10.1097/HJH.0000000000002510.
[8] Nishikawa T,Omura M,Satoh F,et al. Guidelines for the diagnosis and treatment of primary aldosteronism--the Japan Endocrine Society 2009[J]. Endocr J,2011,58(9):711-721.DOI:10.1507/endocrj.ej11-0133.
[9] 郑枫凡,宋颖,杨淑敏,等. 不同方法检测血醛固酮浓度的一致性比较[J]. 中华内分泌代谢杂志,2019,35(11):934-935. DOI:10.3760/cma.j.issn.1000-6699.2019.11.003.
[10] 刘旭. 肾素、醛固酮化学发光定量检测法的性能验证及其对原发性醛固酮增多症筛查效力的评估[J]. 中国卫生检验杂志,2016,26(15):2192-2195. DOI:CNKI:SUN:ZWJZ.0.2016-15-020.
[11] Dorrian CA,Toole BJ,Alvarez-Madrazo S,et al. A screening procedure for primary aldosteronism based on the Diasorin Liaison automated chemiluminescent immunoassay for direct renin[J]. Ann Clin Biochem,2010,47(Pt 3):195-199.DOI:10.1258/acb.2010.009230.
[12] Morganti A; European study group for the validation of DiaSorin LIAISON Direct Renin Assay. A comparative study on inter and intralaboratory reproducibility of renin measurement with a conventional enzymatic method and a new chemiluminescent assay of immunoreactive renin[J]. J Hypertens,2010,28(6):1307-1312.DOI:10.1097/HJH.0b013e32833857ad.
[13] Mulatero P,Rabbia F,Milan A,et al. Drug effects on aldosterone/plasma renin activity ratio in primary aldosteronism[J]. Hypertension,2002,40(6):897-902.DOI:10.1161/01.hyp.0000038478.59760.41.
[14] Song Y,Yang S,He W,et al. Confirmatory tests for the diagnosis of primary aldosteronism:a prospective diagnostic accuracy study[J]. Hypertension,2018,71(1):118-124.DOI:10.1161/HYPERTENSIONAHA.117.10197.
[15] 中华医学会内分泌学分会. 原发性醛固酮增多症诊断治疗的专家共识(2020版)[J]. 中华内分泌代谢杂志,2020,36(9):727-736. DOI:10.3760/cma.j.cn311282-20200615-00444.
[16] Young WF,Stanson AW,Thompson GB,et al. Role for adrenal venous sampling in primary aldosteronism[J]. Surgery,2004,136(6):1227-1235.DOI:10.1016/j.surg.2004.06.051.
[17] Burrello J,Monticone S,Tetti M,et al. Subtype diagnosis of primary aldosteronism:approach to different clinical scenarios[J]. Horm Metab Res,2015,47(13):959-966. DOI:10.1055/s-0035-1565089.
[18] Wachtel H,Zaheer S,Shah PK,et al. Role of adrenal vein sampling in primary aldosteronism:impact of imaging,localization,and age[J]. J Surg Oncol,2016,113(5):532-537.DOI:10.1002/jso.24182.
[19] Zhu L,Zhang Y,Zhang H,et al. Comparison between adrenal venous sampling and computed tomography in the diagnosis of primary aldosteronism and in the guidance of adrenalectomy[J]. Medicine(Baltimore),2016,95(39):e4986.DOI:10.1097/MD.0000000000004986.
[20] Ishidoya S,Ito A,Sakai K,et al. Laparoscopic partial versus total adrenalectomy for aldosterone producing adenoma[J]. J Urol,2005,174(1):40-43.DOI:10.1097/01.ju.0000162045.68387.c3.
[21] Steichen O,Amar L,Chaffanjon P,et al. SFE/SFHTA/AFCE consensus on primary aldosteronism,part 6:adrenal surgery[J]. Ann Endocrinol(Paris),2016,77(3):220-225.DOI:10.1016/j.ando.2016.01.009.
[22] Williams TA,Lenders JWM,Mulatero P,et al. Outcomes after adrenalectomy for unilateral primary aldosteronism:an international consensus on outcome measures and analysis of remission rates in an international cohort[J].Lancet Diabetes Endocrinol,2017,5(9):689-699.DOI:10.1016/S2213-8587(17)30135-3.
相似文献/References:
[1]高海静,温俊平.肾上腺醛固酮腺瘤术后临床转归的影响因素[J].国际内分泌代谢杂志,2016,36(01):58.[doi:10.3760/cma.j.issn.1673-4157.2016.01.015]
Gao Haijing,Wen Junping..Influence factors of postoperative clinical outcomes for patients with adrenal aldosteronoma[J].International Journal of Endocrinology and Metabolism,2016,36(02):58.[doi:10.3760/cma.j.issn.1673-4157.2016.01.015]
[2]钟珊,宋筱筱,徐小红.原发性醛固酮增多症分型诊断研究进展[J].国际内分泌代谢杂志,2020,40(05):327.[doi:10.3760/cma.j.cn121383-20200203-02006]
Zhong Shan,Song Xiaoxiao,Xu Xiaohong.Research progress of subtype diagnosis in primary hyperaldosteronism[J].International Journal of Endocrinology and Metabolism,2020,40(02):327.[doi:10.3760/cma.j.cn121383-20200203-02006]
[3]王慧萍,童安莉.原发性醛固酮增多症相关的基因突变研究进展[J].国际内分泌代谢杂志,2021,41(02):87.[doi:10.3760/cma.j.cn121383-20200706-07013]
Wang Huiping,Tong Anli..Research progress on gene mutation related primary aldosteronism[J].International Journal of Endocrinology and Metabolism,2021,41(02):87.[doi:10.3760/cma.j.cn121383-20200706-07013]
[4]郭富饶,李启富,徐智新.血浆肾素测定方法的新进展及临床意义[J].国际内分泌代谢杂志,2021,41(06):628.[doi:10.3760/cma.j.cn121383-20210315-03038]
Guo Furao,Li Qifu,Xu Zhixin..Advances and clinical value of plasma renin measurement[J].International Journal of Endocrinology and Metabolism,2021,41(02):628.[doi:10.3760/cma.j.cn121383-20210315-03038]
[5]许媛 许岚 张丽华 李启富 杨淑敏.中国原发性醛固酮增多症诊断现状调查研究[J].国际内分泌代谢杂志,2022,42(04):288.[doi:10.3760/cma.j.cn121383-20201221-12058]
Xu Yuan,Xu Lan,Zhang Lihua,et al.Investigation on current status of diagnosis of primary aldosteronism in China[J].International Journal of Endocrinology and Metabolism,2022,42(02):288.[doi:10.3760/cma.j.cn121383-20201221-12058]
[6]谢梦晨,郭洋洋,黄金慧,等.原发性醛固酮增多症基因型与临床表型关系的研究进展[J].国际内分泌代谢杂志,2023,43(03):216.[doi:10.3760/cma.j.cn121383-20220307-03015]
Xie Mengchen,Guo Yangyang,Huang Jinhui,et al.Association of genotype and clinical phenotype of primary aldosteronism[J].International Journal of Endocrinology and Metabolism,2023,43(02):216.[doi:10.3760/cma.j.cn121383-20220307-03015]
[7]王敏 杨宇宏 孙敏.原发性醛固酮增多症的组织病理学新分类及其意义[J].国际内分泌代谢杂志,2023,43(05):372.[doi:10.3760/cma.j.cn121383-20220604-06010]
Wang Min,Yang Yuhong,Sun Min..New histopathological classification of primary aldosteronism and its significance[J].International Journal of Endocrinology and Metabolism,2023,43(02):372.[doi:10.3760/cma.j.cn121383-20220604-06010]